DK0736029T3 - Antikonvulsive pseudofructopyranosesulfamater - Google Patents

Antikonvulsive pseudofructopyranosesulfamater

Info

Publication number
DK0736029T3
DK0736029T3 DK95904333T DK95904333T DK0736029T3 DK 0736029 T3 DK0736029 T3 DK 0736029T3 DK 95904333 T DK95904333 T DK 95904333T DK 95904333 T DK95904333 T DK 95904333T DK 0736029 T3 DK0736029 T3 DK 0736029T3
Authority
DK
Denmark
Prior art keywords
pseudofructopyranose
sulfamates
anticonvulsant
disclosed
compound
Prior art date
Application number
DK95904333T
Other languages
Danish (da)
English (en)
Inventor
Samuel O Nortey
Bruce E Maryanoff
Michael J Costanzo
David F Mccomsey
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/337,597 external-priority patent/US5498629A/en
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK0736029T3 publication Critical patent/DK0736029T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems
DK95904333T 1993-12-23 1994-12-15 Antikonvulsive pseudofructopyranosesulfamater DK0736029T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17339993A 1993-12-23 1993-12-23
US08/337,597 US5498629A (en) 1993-12-23 1994-11-10 Anticonvulsant pseudofructopyranose sulfamates

Publications (1)

Publication Number Publication Date
DK0736029T3 true DK0736029T3 (da) 2006-05-15

Family

ID=26869093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95904333T DK0736029T3 (da) 1993-12-23 1994-12-15 Antikonvulsive pseudofructopyranosesulfamater

Country Status (13)

Country Link
EP (1) EP0736029B1 (de)
JP (1) JP3555032B2 (de)
AT (1) ATE319715T1 (de)
AU (1) AU695336B2 (de)
CA (1) CA2179733C (de)
DE (1) DE69434652T2 (de)
DK (1) DK0736029T3 (de)
ES (1) ES2260761T3 (de)
IL (1) IL112098A (de)
NZ (1) NZ277725A (de)
PT (1) PT736029E (de)
RU (1) RU2139875C1 (de)
WO (1) WO1995017406A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ514813A (en) * 1999-04-08 2004-12-24 Ortho Mcneil Pharm Inc Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
MXPA02000924A (es) 1999-07-26 2003-07-14 Johnson & Johnson Derivados de monosacarido triciclico utiles en el tratamiento de neurodegeneracion inducida por isquemia aguda.
MXPA04004380A (es) * 2001-11-06 2005-06-08 Johnson & Johnson Tratamiento y prevencion de parestesia que comprende co-terapia con derivados anticonvulsivos y potasio.
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
WO2006127184A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
AU2007253814A1 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
AU2009271362B2 (en) 2008-06-23 2014-03-13 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
KR101792999B1 (ko) * 2013-12-12 2017-11-02 (주)바이오팜솔루션즈 간질 예방 또는 치료용 설파메이트 유도체 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates

Also Published As

Publication number Publication date
DE69434652T2 (de) 2007-03-01
NZ277725A (en) 1998-04-27
JPH09507070A (ja) 1997-07-15
ATE319715T1 (de) 2006-03-15
IL112098A0 (en) 1995-03-15
AU695336B2 (en) 1998-08-13
DE69434652D1 (de) 2006-05-04
AU1306795A (en) 1995-07-10
EP0736029A1 (de) 1996-10-09
EP0736029B1 (de) 2006-03-08
JP3555032B2 (ja) 2004-08-18
WO1995017406A1 (en) 1995-06-29
RU2139875C1 (ru) 1999-10-20
ES2260761T3 (es) 2006-11-01
IL112098A (en) 1997-07-13
CA2179733C (en) 2007-03-27
PT736029E (pt) 2006-05-31
CA2179733A1 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
MX9707453A (es) Derivados de quinazolina.
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO996108L (no) 9-oksinerytromycinderivater
AR005999A1 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
EP1026157A3 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
LU88843I2 (fr) Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R)
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
AP9300561A0 (en) Antibiotic compounds.
CS734389A3 (en) 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
SE9504662D0 (sv) New compounds
DE69330601D1 (de) Serotoninergische ergolin derivate
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.